Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Potential CYP51B Inhibitors Against Aspergillus fumigatus. Al Mustansiriyah Journal of Pharmaceutical Sciences, [S. l.], v. 26, n. 3, p. 302–315, 2026. DOI: 10.32947/ajps.v26i3.1420. Disponível em: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1420. Acesso em: 30 sep. 2026.